World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
29866
World Ranking
16469
National Ranking
179

Overview

Ole Schmitz is affiliated with Aarhus University Hospital in Denmark. Their academic profile reflects involvement in medical or clinical research, as indicated by this primary institutional connection.

No recent papers, co-authors, specific publication venues, book publications, or detailed fields of study have been listed in the available data. Consequently, there is no detailed record of the scientist's research outputs, research collaborations, or thematic specializations accessible at this time.

Similarly, no explicit main fields, subfields, or specific research topics have been provided, so it is not possible to delineate their areas of expertise or research focus beyond the association with Aarhus University Hospital.

There is no information about awards or recognitions received by Ole Schmitz, nor any indication of deceased status, so the profile uses present tense and maintains a neutral and factual tone as per guidelines.

Best Publications

  • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

    John A. Dormandy;Bernard Charbonnel;David J A Eckland;Erland Erdmann

  • Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

    D. Russell-Jones;A. Vaag;O. Schmitz;B. K. Sethi

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

    Tina Vilsbøll;Milan Zdravkovic;Tu Le-Thi;Thure Krarup

  • Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin

    S Lund;G D Holman;O Schmitz;O Pedersen

  • One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

    Kristine B. Degn;Claus B. Juhl;Jeppe Sturis;Grethe Jakobsen

  • Effect of nateglinide on the incidence of diabetes and cardiovascular events

    Rury R. Holman;Steven M. Haffner;Steven M. Haffner;John J. McMurray;M. Angelyn Bethel;M. Angelyn Bethel

  • Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.

    Sten Madsbad;Ole Schmitz;Jonas Ranstam;Grethe Jakobsen

  • Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants

    Yingrui Li;Nicolas Vinckenbosch;Geng Tian;Emilia Huerta-Sanchez

  • Bedtime Administration of NN2211, a Long-Acting GLP-1 Derivative, Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes

    Claus B. Juhl;Malene Hollingdal;Jeppe Sturis;Grethe Jakobsen

  • Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects

    Andrea Mari;Ole Schmitz;Amalia Gastaldelli;Torben Oestergaard

  • Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

    Kristine B. Degn;Birgitte Brock;Claus B. Juhl;Christian B. Djurhuus

  • Studies of association of variants near the HHEX , CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects – validation and extension of genome-wide association studies

    Niels Grarup;Chrisian S. Rose;Ehm A. Andersson;Gitte Andersen

  • Long-Term AICAR Administration Reduces Metabolic Disturbances and Lowers Blood Pressure in Rats Displaying Features of the Insulin Resistance Syndrome

    Esben S. Buhl;Niels Jessen;Rasmus Pold;Thomas Ledet

  • GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes.

    Bo Ahrén;O Schmitz

  • Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans.

    C. B. Djurhuus;C. H. Gravholt;S. Nielsen;A. Mengel

  • Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus

    Tina Vilsbøll;B Brock;Hans Perrild;K Levin

  • Amylin Agonists: A Novel Approach in the Treatment of Diabetes

    Ole Schmitz;Birgitte Brock;Jorgen Rungby

  • Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes

    Niels Pørksen;Malene Hollingdal;Claus Juhl;Peter Butler

  • Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner

    Esben S. Buhl;Niels Jessen;Ole Schmitz;Steen B. Pedersen

Frequent Co-Authors

Niels Møller
Niels Møller Aarhus University
Oluf Pedersen
Oluf Pedersen University of Copenhagen
Hans Ørskov
Hans Ørskov Aarhus University Hospital
Hans Erik Bøtker
Hans Erik Bøtker Aarhus University Hospital
Jens Otto Lunde Jørgensen
Jens Otto Lunde Jørgensen Aarhus University Hospital
Steen B. Pedersen
Steen B. Pedersen Aarhus University Hospital
Bjørn Richelsen
Bjørn Richelsen Aarhus University
Jens J. Holst
Jens J. Holst University of Copenhagen
Torben Hansen
Torben Hansen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine involves numerous pathways, many of which can now be started online. For students interested in nursing, there are entry level MSN programs online designed for non-nurses. These programs allow candidates with a non-nursing background to rapidly transition into advanced nursing roles through an accelerated curriculum.

If you are concerned about admission challenges, you may want to investigate what is the easiest nursing school to get into. These institutions often have flexible requirements, making it easier for students to start their healthcare education.

Those drawn to healthcare administration or record keeping can look at medical billing and coding schools that accept financial aid. These programs are ideal for students seeking in-demand, stable roles that support healthcare systems behind the scenes.

Some nursing schools are also removing barriers by offering admission without standardized entrance tests. If you wish to avoid additional exams, consider a nursing school that doesn't require teas exam. This provides greater access and flexibility for aspiring nurses to enter the field.

Best Scientists Citing Ole Schmitz

Recently Published Articles